These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18519037)

  • 1. AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain.
    Wei H; Liu X; Xiong X; Wang Y; Rao Q; Wang M; Wang J
    FEBS Lett; 2008 Jun; 582(15):2167-72. PubMed ID: 18519037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.
    Ibañez V; Sharma A; Buonamici S; Verma A; Kalakonda S; Wang J; Kadkol S; Saunthararajah Y
    Cancer Res; 2004 Jul; 64(13):4547-54. PubMed ID: 15231665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.
    Maiques-Diaz A; Chou FS; Wunderlich M; Gómez-López G; Jacinto FV; Rodriguez-Perales S; Larrayoz MJ; Calasanz MJ; Mulloy JC; Cigudosa JC; Alvarez S
    Leukemia; 2012 Jun; 26(6):1329-37. PubMed ID: 22289984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.
    Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G
    Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
    Nimer SD; Moore MA
    Oncogene; 2004 May; 23(24):4249-54. PubMed ID: 15156180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.
    Choi Y; Elagib KE; Delehanty LL; Goldfarb AN
    Cancer Res; 2006 Mar; 66(6):2990-6. PubMed ID: 16540647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a pluripotent preleukaemic stem cell line by expression of the AML1-ETO fusion protein in Notch1-immortalized HSCN1cl10 cells.
    Delaney C; Bernstein ID
    Br J Haematol; 2004 May; 125(3):353-7. PubMed ID: 15086416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemogenic AML1-ETO fusion protein upregulates expression of connexin 43: the role in AML 1-ETO-induced growth arrest in leukemic cells.
    Li X; Xu YB; Wang Q; Lu Y; Zheng Y; Wang YC; Lübbert M; Zhao KW; Chen GQ
    J Cell Physiol; 2006 Sep; 208(3):594-601. PubMed ID: 16741927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
    Peterson LF; Lo MC; Okumura AJ; Zhang DE
    Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
    Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
    Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G
    Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta.
    Qiu J; Wong J; Tweardy DJ; Dong S
    Oncogene; 2006 Jun; 25(28):3982-93. PubMed ID: 16474840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of AML1B and AML1/ETO on the transactivation of TSC genes.].
    Xu ZF; Wang L; Wang Y; Wang M; Rao Q; Xing HY; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2009 Dec; 30(12):804-7. PubMed ID: 20193599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line.
    Zhuang WY; Cen JN; Zhao Y; Chen ZX
    Oncol Rep; 2013 Jul; 30(1):185-92. PubMed ID: 23673926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity.
    Liu Y; Cheney MD; Gaudet JJ; Chruszcz M; Lukasik SM; Sugiyama D; Lary J; Cole J; Dauter Z; Minor W; Speck NA; Bushweller JH
    Cancer Cell; 2006 Apr; 9(4):249-60. PubMed ID: 16616331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.
    de Guzman CG; Warren AJ; Zhang Z; Gartland L; Erickson P; Drabkin H; Hiebert SW; Klug CA
    Mol Cell Biol; 2002 Aug; 22(15):5506-17. PubMed ID: 12101243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETO interacting proteins.
    Hug BA; Lazar MA
    Oncogene; 2004 May; 23(24):4270-4. PubMed ID: 15156183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E protein silencing by the leukemogenic AML1-ETO fusion protein.
    Zhang J; Kalkum M; Yamamura S; Chait BT; Roeder RG
    Science; 2004 Aug; 305(5688):1286-9. PubMed ID: 15333839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIG7, transactivated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1-ETO fusion gene.
    Liu J; Xing H; Chen Y; Wang L; Wang D; Rao Q; Tang K; Tian Z; He K; Wang M; Wang J
    Leukemia; 2012 Jan; 26(1):117-26. PubMed ID: 21836606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.